How hyperglycemia promotes atherosclerosis: molecular mechanisms.
about
Cardiovascular diabetology in the core of a novel interleukins classification: the bad, the good and the aloofReceptor for advanced glycation end products and its involvement in inflammatory diseasesUric acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttleVascular ossification-calcification in metabolic syndrome, type 2 diabetes mellitus, chronic kidney disease, and calciphylaxis-calcific uremic arteriolopathy: the emerging role of sodium thiosulfateIntimal redox stress: accelerated atherosclerosis in metabolic syndrome and type 2 diabetes mellitus. Atheroscleropathy.Influence of diabetes mellitus on heart failure risk and outcomeThe central role of vascular extracellular matrix and basement membrane remodeling in metabolic syndrome and type 2 diabetes: the matrix preloaded.Vascular Effects of Dietary Advanced Glycation End ProductsObesity, Oxidative Stress, Adipose Tissue Dysfunction, and the Associated Health Risks: Causes and Therapeutic StrategiesAsymmetric subcellular distribution of glucose transporters in the endothelium of small contractile arteriesA novel mechanism for antiglycative action of limonene through stabilization of protein conformation.Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans.Phagocytosis of cholesteryl ester is amplified in diabetic mouse macrophages and is largely mediated by CD36 and SR-A.Assessment of metabolic status in young Japanese females using postprandial glucose and insulin levelsSOCS3 overexpression inhibits advanced glycation end product-induced EMT in proximal tubule epithelial cellsEffect of Dark Chocolate Extracts on Phorbol 12-Myristate 13-Acetate-Induced Oxidative Burst in Leukocytes Isolated by Normo-Weight and Overweight/Obese Subjects.Rapamune does not attenuate high cholesterol-induced atherosclerosis in rabbits.Differentially Expressed MicroRNAs in the Development of Early Diabetic Retinopathy.Lowering low-density lipoprotein cholesterol levels in patients with type 2 diabetes mellitus.Chromosome 9p21.3 polymorphism in a Chinese Han population is associated with angiographic coronary plaque progression in non-diabetic but not in type 2 diabetic patients.Metabolic memory: a vascular perspective.A structural model that explains the effects of hyperglycemia on collagenolysis.Comparison of carotid and lower limb atherosclerotic lesions in both previously known and newly diagnosed type 2 diabetes mellitusHow do high glycemic load diets influence coronary heart disease?The effects of antidepressants "fluoxetine and imipramine" on vascular abnormalities and Toll like receptor-4 expression in diabetic and non-diabetic rats exposed to chronic stress.The mechanism by which moderate alcohol consumption influences coronary heart disease.Cyclophilin A is associated with peripheral artery disease and chronic kidney disease in geriatrics: The Tianliao Old People (TOP) studyAnatomy of coronary disease in diabetic patients: an explanation for poorer outcomes after percutaneous coronary intervention and potential target for interventionDietary advanced glycation end products and aging.Synchrotron infrared imaging of advanced glycation endproducts (AGEs) in cardiac tissue from mice fed high glycemic diets.Frequent non-cardiac comorbidities in patients with chronic heart failure.Linkage of epidemiologic evidence with the clinical aspects of metabolic syndrome.Effects of rosiglitazone with insulin combination therapy on oxidative stress and lipid profile in left ventricular muscles of diabetic ratsPrevious gestational diabetes is independently associated with increased carotid intima-media thickness, similarly to metabolic syndrome - a case control study.Glycaemic control is essential for effective cardiovascular risk reduction across the type 2 diabetes continuum.Urinary Malondialdehyde Is Associated with Visceral Abdominal Obesity in Middle-Aged MenRuboxistaurin, a protein kinase C beta inhibitor, as an emerging treatment for diabetes microvascular complications.Association between HbA1c and carotid atherosclerosis among elderly Koreans with normal fasting glucoseMannose-Binding Lectin Levels and Carotid Intima-Media Thickness in Type 2 Diabetic PatientsImpact of Nutrition on Cerebral Circulation and Cognition in the Metabolic Syndrome.
P2860
Q21246039-FAF03889-1C96-4A2A-8ED8-8D7FAD7CB9B9Q21285070-1D502F9D-32D8-450B-9EE5-742474C8A169Q24559986-29958D9F-2B8B-479A-A7B3-1CD06F6448BFQ24795302-D05CEC6D-610E-41CA-B10A-02EAB15EB798Q24796491-36809607-55B8-4A04-9ED3-2DE319D106B2Q24800363-E50CA5C6-754D-40B8-9A36-963CEF5CC0BFQ24811354-1D65AAF9-2E2A-44E4-B44B-7BA5ECE400DEQ28081090-1F996ADE-E733-4987-99D1-6F92FB245E89Q28088325-1BEA42A7-34BC-4079-80C3-21602551EB34Q28574705-4A27B60C-5BEF-481F-BC15-B5997D930409Q30352232-C7EF39D8-9008-4D39-BA65-1E0C22EFE881Q30438756-9E57470C-CF48-4C0B-BE31-43A76FE5FB96Q33286823-51842354-3C34-47B5-BCF2-28227BC7C0C1Q33701724-F40BDB3F-28CE-4067-AA39-DEC0C4696992Q33744838-3B832001-51F7-4947-AEF3-87A5B50DAEF3Q33780573-DA0DD449-C580-4429-BE3E-B6061FEA8363Q33848041-64E4F03D-2099-4F2E-99F5-AA575CCE1235Q33863708-D2486610-C34D-4795-8029-BA938E21BA31Q33890208-6303CCA3-B2A4-454E-8ABB-5AB48B813406Q34075000-D2564E59-F466-433F-8DAD-9D32ACCD7162Q34158068-6EE5E6CB-E2AF-454C-8813-DAED006D7BA3Q34183042-569398BA-3DC1-4A3E-AD0F-5B0657D97328Q34523776-50771155-721F-4DE5-B027-782947ADEA08Q35177141-19CD7F43-7F26-4784-AA06-A2FDD7CB797EQ35235141-DF284170-908D-443C-A714-8D6F279FF834Q35315854-AA249214-25A0-4643-8C20-0A78918856D7Q35535488-FF033FB0-3E98-49D4-B658-8F0F4D49C9E0Q35582568-CA1A39DB-014D-4337-A141-35C530063BA6Q35670859-C8628B62-14AC-4A80-89C2-D725293C7459Q35821049-3662FE47-D54C-43AB-AEBB-9CB8E36B92CCQ36046585-BAB2CCFC-CFCE-4588-A9EB-B848BA7F4312Q36078200-B185A298-3DC1-4931-9102-7B42B5DB17BAQ36100004-D5F0AFD9-905B-4AAA-8DD9-D772351AAC8DQ36112708-F786B63F-294F-4736-9B13-F50F23B407D6Q36194911-EBC4AFFE-0E0A-4756-87A5-673D024E4F78Q36204530-A96F8404-0A21-48DC-95C3-90183F85F597Q36256287-DBE9B0B9-2592-4EF4-ACFC-8C5CE47E2374Q36274187-8D542C16-0DB9-4826-ACFB-B170B0B9BD17Q36310396-74E28F06-0014-46C7-A9BC-EA073B8F1BB4Q36329909-AE261CA5-B7A3-4506-A275-95513FF59438
P2860
How hyperglycemia promotes atherosclerosis: molecular mechanisms.
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
How hyperglycemia promotes atherosclerosis: molecular mechanisms
@nl
How hyperglycemia promotes atherosclerosis: molecular mechanisms.
@ast
How hyperglycemia promotes atherosclerosis: molecular mechanisms.
@en
type
label
How hyperglycemia promotes atherosclerosis: molecular mechanisms
@nl
How hyperglycemia promotes atherosclerosis: molecular mechanisms.
@ast
How hyperglycemia promotes atherosclerosis: molecular mechanisms.
@en
prefLabel
How hyperglycemia promotes atherosclerosis: molecular mechanisms
@nl
How hyperglycemia promotes atherosclerosis: molecular mechanisms.
@ast
How hyperglycemia promotes atherosclerosis: molecular mechanisms.
@en
P2860
P3181
P356
P1476
How hyperglycemia promotes atherosclerosis: molecular mechanisms.
@en
P2093
Doron Aronson
Elliot J Rayfield
P2860
P2888
P3181
P356
10.1186/1475-2840-1-1
P407
P577
2002-04-08T00:00:00Z
P5875
P6179
1046364278